CompletedNot Applicable

Does Tracheal Suction During Extubation in Intensive Care Unit Decrease Functional Residual Capacity

France60 participantsStarted 2015-10-27

Plain-language summary

Little is known about the procedure of extubation of patients admitted in Intensive Care Units (ICU). In particular, effects of tracheal suction during extubation have never been evaluated. Tracheal suction induces alveolar derecruitment in sedated patients under mechanical ventilation and is a major source of pain. The aim of this study was to evaluate the impact of tracheal suction during the extubation procedure of critically ill patients on the end-expiratory lung volume.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * age of 18 years or more * hospitalization in the surgical ICU (whatever the cause of hospitalization) * under mechanical ventilation via a tracheal tube (oro or nasotracheal) for at least 24 hours * satisfying general criteria for mechanical ventilation weaning (described by the French Language Resuscitation Society) * having successfully completed a spontaneous breathing trial (among those described by the SRLF) * physiotherapist available during the first hour after extubation Exclusion Criteria: * the presence of an electrical implantable medical device (pacemaker, automatic defibrillator, deep brain stimulation box) * body mass index (BMI) \> 50 * pregnancy * tracheal tube with subglottic suction channel * technical impossibility of monitoring by electrical impedance tomography (chest plaster, undrained pneumothorax, ...).

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

ΔEELI 15

Timeframe: 15 minutes after extubation

Trial details

NCT IDNCT03681626

SponsorUniversity Hospital, Rouen

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-08-31

View on ClinicalTrials.gov More Critically Ill trials